Analyze Diet

Topic:Disease Prevention

Disease prevention in horses encompasses strategies and practices aimed at minimizing the occurrence and spread of infectious and non-infectious diseases within equine populations. These practices include vaccination programs, biosecurity measures, and regular health monitoring. Vaccination helps to stimulate the horse's immune system to protect against specific pathogens, while biosecurity measures, such as quarantine and sanitation, reduce the risk of disease transmission. Regular health monitoring, including physical examinations and diagnostic testing, aids in early detection and management of potential health issues. This page compiles peer-reviewed research studies and scholarly articles that explore various methods and their effectiveness in preventing diseases in horses, as well as the development and implementation of prevention programs in different equine settings.
Use of veterinary clinic records for evaluating possible risk factors for disease.
Australian veterinary journal    November 1, 1996   Volume 74, Issue 5 365-366 doi: 10.1111/j.1751-0813.1996.tb15446.x
Morton JM.No abstract available
Yew poisoning in horses.
The Canadian veterinary journal = La revue veterinaire canadienne    November 1, 1996   Volume 37, Issue 11 687 
Parkinson N.No abstract available
An account on equine babesioses.
Revue scientifique et technique (International Office of Epizootics)    September 1, 1996   Volume 15, Issue 3 1191-1201 doi: 10.20506/rst.15.3.972
Friedhoff KT, Soulé C.A review of the distribution of Babesia equi and Babesia caballi, the transmission of these protozoa by ticks and the immune response of infected horses, in addition to a brief survey of diagnostic. tests and chemotherapy.
Investigation of a second focus of equine morbillivirus infection in coastal Queensland.
Australian veterinary journal    September 1, 1996   Volume 74, Issue 3 243-244 doi: 10.1111/j.1751-0813.1996.tb15413.x
Rogers RJ, Douglas IC, Baldock FC, Glanville RJ, Seppanen KT, Gleeson LJ, Selleck PN, Dunn KJ.No abstract available
Effect of progesterone on prostaglandin F2 alpha secretion and outcome of pregnancy during cloprostenol-induced abortion in mares.
American journal of veterinary research    September 1, 1996   Volume 57, Issue 9 1331-1337 
Daels PF, Besognet B, Hansen B, Mohammed H, Odensvik K, Kindahl H.To determine the role of progesterone in the regulation of endogenous prostaglandin F2 alpha (PGF2 alpha) secretion during cloprostenol-induced abortion and to investigate use of progestins to prevent prostaglandin-associated abortion. Methods: 16 pregnant mares. Methods: To induce abortion, cloprostenol (250 micrograms/d) was administered daily until fetal expulsion or for up to 5 days. In experiment 1, 8 mares, 98 to 153 days' pregnant, received progesterone (300 mg/d) at 24-hour intervals for 5 days, starting 18 hours after the first cloprostenol administration. In experiment 2, 8 mares, 93...
Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer-capsid protein VP2 provides protection against virulent AHSV challenge.
The Journal of general virology    September 1, 1996   Volume 77 ( Pt 9) 2053-2057 doi: 10.1099/0022-1317-77-9-2053
Roy P, Bishop DH, Howard S, Aitchison H, Erasmus B.African horsesickness virus serotype 4 (AHSV-4) outer-capsid proteins VP2 or VP2 and VP5, prepared from single or dual recombinant baculovirus expression vectors grown in Sf9 insect cells, were administered in different amounts to horses and the neutralizing antibody responses were measured. Control and vaccinated horses were challenged with virulent AHSV-4 6 months later and monitored post challenge. The results indicated that two inoculations of extracts containing VP2 and VP5, or VP2 alone, in doses of 5 micrograms VP2 or more per horse, were sufficient to elicit protection against African ...
Instrument sterilization, skin preparation, and wound management.
The Veterinary clinics of North America. Equine practice    August 1, 1996   Volume 12, Issue 2 173-194 doi: 10.1016/s0749-0739(17)30278-x
Southwood LL, Baxter GM.Recent advances in instrument sterilization include the introduction of gas plasma sterilization and the increased use of glutaraldehyde. Gas plasma sterilization has the advantages of no toxic residue effects, reduced turnover time, and applicability for sterilization of heat- and moisture-sensitive instruments. Chlorhexidine gluconate (4%) appears to be a superior preoperative surgical scrub for both the surgeon and the patient because of its increased antimicrobial efficacy, residual activity, and minimal tissue reactions. There are many new wound dressings and topical medications for treat...
Workshop summary: equine parasitology.
Veterinary parasitology    August 1, 1996   Volume 64, Issue 1-2 163-166 doi: 10.1016/0304-4017(96)00985-5
Klei TR.No abstract available
Control of an outbreak of salmonellosis caused by drug-resistant Salmonella anatum in horses at a veterinary hospital and measures to prevent future infections.
Journal of the American Veterinary Medical Association    August 1, 1996   Volume 209, Issue 3 629-631 
Hartmann FA, Callan RJ, McGuirk SM, West SE.Salmonella anatum was isolated from horses treated at a private veterinary clinic or at a university veterinary medical teaching hospital. All isolates were resistant to most commonly used antibiotics. Because of the severity of disease resulting from outbreaks of infections with drug-resistant strains of S anatum, an epidemiologic investigation was conducted. Enteric bacteria, including S anatum, that were resistant to most antibiotics were isolated from the private veterinary clinic environment. Salmonella anatum was not isolated from the university teaching hospital environment. To prevent ...
Multiple gene expression in baculovirus system. Third generation vaccines for bluetongue disease and African horsesickness disease.
Annals of the New York Academy of Sciences    July 23, 1996   Volume 791 318-332 doi: 10.1111/j.1749-6632.1996.tb53539.x
Roy P.No abstract available
Zoonoses control. Equine morbillivirus in Queensland.
Releve epidemiologique hebdomadaire    July 5, 1996   Volume 71, Issue 27 208-210 
No abstract available
[Development of resistance to antiparasitic agents in parasites pathogenic to animals].
DTW. Deutsche tierarztliche Wochenschrift    July 1, 1996   Volume 103, Issue 7 260-263 
Daugschies A.Drug resistance of parasites is a worldwide problem of increasing importance in animal production. Considerable information is available on the development of resistance in chicken coccidia and in strongyles of horses, sheep, goats and pigs. A review is given of the development, incidence, and management of drug resistance with emphasis on the situation in Germany.
Joint disease–a role for serum markers in diagnosis, control and prevention.
The British veterinary journal    July 1, 1996   Volume 152, Issue 4 373-375 doi: 10.1016/s0007-1935(96)80032-7
Thorp B.No abstract available
Equine herpesvirus type 2 (EHV-2) as a predisposing factor for Rhodococcus equi pneumonia in foals: prevention of the bifactorial disease with EHV-2 immunostimulating complexes.
Veterinary microbiology    July 1, 1996   Volume 51, Issue 1-2 55-68 doi: 10.1016/0378-1135(96)00032-6
Nordengrahn A, Rusvai M, Merza M, Ekström J, Morein B, Belák S.Equine herpesvirus type 2 (EHV-2), a member of the Gammaherpesvirinae subfamily, was studied in a two-phase respiratory disease complex of young foals as a predisposing factor for the secondary bacterial invasion of lungs with Rhodococcus equi (R. equi). Foals were immunized against EHV-2 on a farm where R. equi pneumonia regularly occurred during the last years. The immunizations were performed by using a subunit vaccine which selectively presents envelope glycoproteins of EHV-2 in a multimeric form of immunostimulating complexes (iscoms). The etiological role of EHV-2 was estimated by observ...
The capacity of the fungus Duddingtonia flagrans to prevent strongyle infections in foals on pasture.
Parasitology    July 1, 1996   Volume 113 ( Pt 1) 1-6 doi: 10.1017/s003118200006621x
Larsen M, Nansen P, Grøndahl C, Thamsborg SM, Grønvold J, Wolstrup J, Henriksen SA, Monrad J.A field trial was conducted to evaluate the potential of the nematode-destroying fungus Duddingtonia flagrans to control free-living stages of horse strongyles. In late Spring 2 groups of horses (yearlings) with mixed infections of strongyles were allowed to contaminate 2 equal-sized pastures. One of the groups (F) received a daily dose of D. flagrans mixed in a feed supplement, while the other (C) received a similar amount of supplement without fungus. During a 3-month contamination period strongyle egg counts in faeces and number of infective strongyle larvae harvested from faecal cultures w...
Evaluation of outbreaks of disease attributable to eastern equine encephalitis virus in horses.
Journal of the American Veterinary Medical Association    June 15, 1996   Volume 208, Issue 12 1988-1997 
Ross WA, Kaneene JB.To evaluate outbreaks of disease attributable to eastern equine encephalitis virus (EEEV) in horses in Michigan, and the associated environmental patterns and weather conditions, so that factors could be identified that may have predisposed horses in specific areas of the state to infections with EEEV. Methods: Epidemiologic retrospective records analysis. Methods: Data on EEEV vectors, wild-bird reservoir hosts, and incidental hosts, including horses and human beings, obtained from census reports and medical records compiled between 1942 and 1991. Methods: Patterns detected during outbreaks o...
The incidence and consequences of failure of passive transfer of immunity on a thoroughbred breeding farm.
Australian veterinary journal    June 1, 1996   Volume 73, Issue 6 201-206 doi: 10.1111/j.1751-0813.1996.tb10035.x
Raidal SL.Circulating IgG concentration was determined between 12 and 24 hours after birth for 323 foals born on a Thoroughbred breeding farm over 3 consecutive years. The incidence of failure of passive transfer (FPT) of maternal immunoglobulins (foal circulating IgG concentration < 8 g/L) was found to be 9.6%. Foals born late in the season (October to December) were found to be at increased risk for the development of FPT. The degree of assistance required at parturition and the presence of a periparturient problem in the mare or foal also significantly influenced the subsequent incidence of FPT. Pass...
Immunization with VP2 is sufficient for protection against lethal challenge with African horsesickness virus Type 4.
Virology    June 1, 1996   Volume 220, Issue 1 219-222 doi: 10.1006/viro.1996.0304
Stone-Marschat MA, Moss SR, Burrage TG, Barber ML, Roy P, Laegreid WW.Horses were immunized by inoculation with a vaccinia construct containing a full-length cDNA corresponding to the L2 gene segment of African horsesickness virus type 4(AHSV-4). All immunized horses developed serum neutralizing antibodies prior to challenge with virulent AHSV-4. No ELISA-reactive antibodies were present prior to challenge. A group of four seronegative control horses died after developing clinical signs and lesions typical of the pulmonary form of African horsesickness while the immunized horses were clinically normal. Increases in serum neutralizing and ELISA-reactive antibody ...
Contagious equine metritis.
Comparative immunology, microbiology and infectious diseases    June 1, 1996   Volume 19, Issue 3 199-204 doi: 10.1016/0147-9571(96)00005-7
Timoney PJ.Contagious equine metritis (CEM) is a highly contagious venereal infection of equids caused by Taylorella equigenitalis, a bacterium with fastidious growth requirements. A disease of major international concern, CEM can be the cause of short-term infertility and, very rarely, abortion in mares. Unlike the mare, stallions exposed to T. equigenitalis do not develop clinical signs of disease. CEM is transmitted by direct or indirect venereal contact. The carrier state occurs in the mare and the stallion and carrier animals are frequently the source of infection for new outbreaks of the disease. T...
Full protection against African horsesickness (AHS) in horses induced by baculovirus-derived AHS virus serotype 4 VP2, VP5 and VP7.
The Journal of general virology    June 1, 1996   Volume 77 ( Pt 6) 1211-1221 doi: 10.1099/0022-1317-77-6-1211
Martínez-Torrecuadrada JL, Díaz-Laviada M, Roy P, Sánchez C, Vela C, Sánchez-Vizcaíno JM, Casal JI.African horsesickness virus serotype 4 (AHSV-4) outer capsid protein VP2, or VP2 and VP5 plus inner capsid protein VP7, derived from single or dual recombinant baculovirus expression vectors were used in different combinations to immunize horses. When the proteins were purified by affinity chromatography, the combination of all three proteins induced low levels of neutralizing antibodies and conferred protection against virulent virus challenge. However, purified VP2 or VP2 and VP5 in the absence of VP7 failed to induce neutralizing antibodies and protection. Immunization with non-purified pro...
Equine influenza.
Comparative immunology, microbiology and infectious diseases    June 1, 1996   Volume 19, Issue 3 205-211 doi: 10.1016/0147-9571(96)00006-9
Timoney PJ.A highly contagious virus infection of horses, influenza is the single most important equine respiratory disease in many countries. Two subtypes of equine influenza virus have been identified, A/equine-1 and A/equine-2, neither of which immunologically cross-reacts. In the case of A/equine-2 virus, two lineages exist, American and European, which appear to have evolved independently of one another. The acute febrile respiratory disease characteristic of influenza is frequently complicated by secondary bacterial infection, especially in unvaccinated horses. Primarily a respiratory-borne infecti...
Clinical application of interferons in large animal medicine.
Journal of the American Veterinary Medical Association    May 15, 1996   Volume 208, Issue 10 1711-1715 
Moore BR.Interferons are efficacious therapeutic agents for treatment of several clinically important diseases in cattle and horses. In some instances, the therapeutic goal of IFN administration is prevention or clinical cure of acute viral infections. On the other hand, IFN may serve as adjunctive treatment to diminish clinical manifestations of disease and improve the quality of life. Oral administration of IFN alpha appears to be a safe and convenient route of administration, and the therapeutic benefit likely develops via unique mechanisms involving oropharyngeal-associated lymphoid tissue for diss...
Effect of vaccination of ponies with A4 anti-idiotypic antibody on serum idiotype (1C9) and antilipid A concentration.
American journal of veterinary research    May 1, 1996   Volume 57, Issue 5 655-658 
BonenClark GD, MacKay RJ, Ward RE, Sheerin B.To evaluate the humoral response of horses to vaccination, using a murine monoclonal anti-idiotypic antibody (A4) that shares an epitope with lipid A. Methods: Serum concentrations of antilipid A antibody and 1C9 (epitope on murine monoclonal antilipid A antibody) were measured serially during the period of vaccination with A4. Methods: 6 clinically normal adult ponies. Methods: Ponies were inoculated IM 3 times at monthly intervals with A4. Two weeks after each inoculation, serum was obtained and was assayed by ELISA for antilipid A and 1C9 concentrations. Additional vaccinations were given t...
Benefit-cost analysis of vaccination of horses as a strategy to control equine monocytic ehrlichiosis.
Journal of the American Veterinary Medical Association    April 15, 1996   Volume 208, Issue 8 1295-1299 
Atwill ER, Mohammed HO.To determine whether horses in New York should be vaccinated against equine monocytic ehrlichiosis (EME). Methods: Decision-tree analyses of data from a cross-sectional study and a case-control study. Methods: Horses in New York. Methods: Annual expected monetary loss per horse attributable to EME was calculated for vaccinated and nonvaccinated horses in New York. Because risk of being seropositive was dependent on county in which the horse was located, farm elevation, and use of each horse, decision-tree analyses were stratified by these factors. Results: Annual expected monetary loss per hor...
Characterization of protective and enhancing immune responses to equine infectious anemia virus resulting from experimental vaccines.
AIDS research and human retroviruses    March 20, 1996   Volume 12, Issue 5 413-415 doi: 10.1089/aid.1996.12.413
Montelaro RC, Grund C, Raabe M, Woodson B, Cook RF, Cook S, Issel CJ.No abstract available
Equine babesiosis (piroplasmosis): a problem in the international movement of horses.
The British veterinary journal    March 1, 1996   Volume 152, Issue 2 123-126 doi: 10.1016/s0007-1935(96)80066-2
Knowles D.No abstract available
Equine piroplasmosis an update on diagnosis, treatment and prevention.
The British veterinary journal    March 1, 1996   Volume 152, Issue 2 139-151 doi: 10.1016/s0007-1935(96)80070-4
Brüning A.Two haemoprotozoan parasites, Babesia caballi and Babesia equi, can cause equine piroplasmosis. Due to the presence of potential tick vectors in areas so far unaffected by equine babesias, import and export regulations often require the serum testing of animals for evidence of infection. Although the complement fixation test (CFT) has been recommended for detecting the presence of antibodies to Babesia spp., it has been demonstrated to have several disadvantages, including false-positive results and low sensitivity for detecting latent infections. An enzyme-linked immunosorbent assay (ELISA) m...
Effects of posture and accumulated airway secretions on tracheal mucociliary transport in the horse.
Australian veterinary journal    February 1, 1996   Volume 73, Issue 2 45-49 doi: 10.1111/j.1751-0813.1996.tb09963.x
Raidal SL, Love DN, Bailey GD.Tracheal mucociliary clearance was determined in horses by measuring the rostrad transport of the radiopharmaceutical 99mtechnetium-sulphur colloid following deposition on the tracheal epithelium by intratracheal injection. The effects of head position (head elevated to normal standing position vs head lowered) and of accumulated purulent secretions on tracheal mucociliary clearance were evaluated for the first time in the horse. In normal horses tracheal mucociliary clearance was greatly accelerated by lowering the head so that the cranial trachea was lower than the caudal trachea. Horses con...
Lack of virulence of the murine fibroblast adapted strain, Kentucky A (KyA), of equine herpesvirus type 1 (EHV-1) in young horses.
Veterinary microbiology    February 1, 1996   Volume 48, Issue 3-4 353-365 doi: 10.1016/0378-1135(09)59999-3
Matsumura T, O'Callaghan DJ, Kondo T, Kamada M.The virulence of the cell culture adapted KyA strain of equine herpesvirus type 1 (EHV-1), which lacks at least six genes by deletions in its genome, was assessed by intranasal inoculation of six young horses that were serologically negative for EHV-1. No horses showed clinical signs, and a neutralizing antibody response against EHV-1 was detected in two horses which had antibodies against EHV-4 prior to the inoculation. A challenge experiment using a highly virulent strain of EHV-1 conducted 4 weeks later against 4 of the 6 horses inoculated intranasally with the KyA strain and 2 control hors...
[Spectrum of species and incidence of endoparasites in foals and their mother mares from breeding farms with and without anthelmintic prophylaxis in upper Bavaria].
Tierarztliche Praxis    February 1, 1996   Volume 24, Issue 1 48-54 
Beelitz P, Göbel E, Gothe R.In this epidemiological study 37 foals and mares were included, which have been coproscopically examined in regular intervals over a period lasting up to 13 months. The animals derived from nine breeding farms. In three of these farms no anthelmintics were used before this investigation, whereas in six farms at least three years before regular prophylactic treatments with anthelmintics have been carried out. This investigation revealed no differences in the species spectrum of endoparasites as well as in the incidence of infections as regards to the breeding farms with and without anthelmintic...
1 77 78 79 80 81 119